Sacroiliac Joint Injection Covered Indications
David Rosenblum, MD, an interventional pain physician based in Long Island, discusses sacroiliac joint dysfunction and the indications for sacroiliac joint injection and diagnostic nerve block covered by CMS. Sacroiliac Joint Injections are considered necessary and reasonable when certain criteria are met, including moderate to severe low back pain primarily experienced over the anatomical location of the SI joints and low back pain duration of at least three months. Additionally, clinical findings and/or imaging studies should not suggest any other diagnosed or obvious cause of the lumbosacral pain, and at least three positive findings with provocative maneuvers should be present. The post also includes a list of upcoming regenerative pain medicine and ultrasound training courses. The reference for this post is included for readers to access further information.
Sacroiliac joint dysfunction is a common cause of low back pain, affecting up to 25% of patients with chronic lower back pain. The sacroiliac joint is located between the sacrum and the ilium, connecting the spine to the pelvis. Dysfunction of this joint can result in pain in the lower back, hips, and legs.
Diagnosis of sacroiliac joint dysfunction can be challenging, as the symptoms can mimic those of other conditions such as herniated discs or spinal stenosis. However, there are several diagnostic tests that can be performed to help identify sacroiliac joint dysfunction, including provocative maneuvers such as the FABER test and the Gaenslen test.
Treatment for sacroiliac joint dysfunction typically involves conservative therapies such as physical therapy, chiropractic care, and medications such as nonsteroidal anti-inflammatory drugs (NSAIDs). In cases where conservative therapies are ineffective, sacroiliac joint injections may be considered. These injections involve injecting a combination of local anesthetic and corticosteroid medication into the joint to provide pain relief.
Unfortunately, 2 possible long term treatments, Platelet Rich Plasma and Radiofrequency Ablation of the Sacroiliac Joint are not considered medically necessary and are not covered by CMS.